Novel production of a new oral vaccine for COVID-19 with a recombinant Bacillus subtilis strain
- Funded by Natural Sciences and Engineering Research Council of Canada (NSERC)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$36,176Funder
Natural Sciences and Engineering Research Council of Canada (NSERC)Principal Investigator
Simon BarnabéResearch Location
CanadaLead Research Institution
Québec à Trois-RivièresResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementationResearch Subcategory
Pre-clinical studiesSpecial Interest Tags
InnovationStudy Type
Not applicableClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
Medical and health sciences